What changed?
A sourced timeline of research records and material development changes tracked by BACToBasics for Tesamorelin. Research-publication dates and clinical-development event dates are labeled separately so they are not mistaken for the same type of update.
Tracked items
3
Research sources
2
Development entries
1
Latest recorded date
Verified 2026-09-05
Latest development activity
Verified 2026-09-05 · Approved · Approved
Tesamorelin completed late-stage development and has FDA-approved EGRIFTA products for a specific HIV-associated lipodystrophy indication.
Open source ↗Latest research record by publication date
Published 2010 · Human intervention · Randomized placebo-controlled trial
This randomized trial and extension evaluated visceral fat, body composition, IGF-1, glucose measures, and safety over up to 12 months.
Open source ↗Tracked timeline
Development changes are dated to the underlying milestone. Research-source entries use the study or source publication year currently stored in the Research Library; that year is not presented as the date BACToBasics added the record.
Approved · Approved
Tesamorelin completed late-stage development and has FDA-approved EGRIFTA products for a specific HIV-associated lipodystrophy indication.
Human intervention · Randomized placebo-controlled trial
This randomized trial and extension evaluated visceral fat, body composition, IGF-1, glucose measures, and safety over up to 12 months.
Human intervention · Pooled Phase 3 randomized trials
A pooled analysis of two Phase 3 randomized trials documented tesamorelin's effects on visceral adipose tissue in its clinical development population.
Following a compound creates a clean baseline from the updates currently known. When BACToBasics later records a new research source or material development change, the My Tools update badge can surface it as new for you.
BACToBasics provides educational research organization only. A development milestone does not predict future approval, and a research record does not establish that a compound is safe, effective, approved, or appropriate for use.